161 related articles for article (PubMed ID: 38170742)
1. Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes.
Paudel BB; Tan SF; Fox TE; Ung J; Golla U; Shaw JJP; Dunton W; Lee I; Fares WA; Patel S; Sharma A; Viny AD; Barth BM; Tallman MS; Cabot M; Garrett-Bakelman FE; Levine RL; Kester M; Feith DJ; Claxton D; Janes KA; Loughran TP
Blood Adv; 2024 Mar; 8(5):1137-1142. PubMed ID: 38170742
[No Abstract] [Full Text] [Related]
2. Characteristics and clinical behavior of acute myeloid leukemia harboring rare non-A/B/D nucleophosmin (
Mutti M; Cordella S; Parisotto A; Bettelli F; Morselli M; Cuoghi A; Bresciani P; Messerotti A; Gilioli A; Pioli V; Giusti D; Colaci E; Cassanelli L; Paolini A; Martinelli S; Maffei R; Riva G; Nasillo V; Sarti M; Trenti T; Comoli P; Tagliafico E; Manfredini R; Eccher A; Lagreca I; Barozzi P; Potenza L; Marasca R; Candoni A; Luppi M; Forghieri F
Leuk Lymphoma; 2024 Apr; 65(4):511-515. PubMed ID: 38112426
[No Abstract] [Full Text] [Related]
3. A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis.
Woolthuis CM; Mulder AB; Verkaik-Schakel RN; Rosati S; Diepstra A; van den Berg E; Schuringa JJ; Vellenga E; Kluin PM; Huls G
Haematologica; 2013 Oct; 98(10):1532-8. PubMed ID: 23716555
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes.
Paudel BB; Tan SF; Fox TE; Ung J; Shaw J; Dunton W; Lee I; Sharma A; Viny AD; Barth BM; Tallman MS; Cabot M; Garrett-Bakelman FE; Levine RL; Kester M; Claxton D; Feith DJ; Janes KA; Loughran TP
bioRxiv; 2023 Apr; ():. PubMed ID: 37131653
[TBL] [Abstract][Full Text] [Related]
5. NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation.
Raman HS; Shanmugam V; Li J; Steensma DP; Kim AS; Luskin MR
Leuk Lymphoma; 2021 Jul; 62(7):1790-1792. PubMed ID: 33586600
[No Abstract] [Full Text] [Related]
6. Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene.
Jeziskova I; Razga F; Toskova M; Dvorakova D; Timilsina S; Mayer J; Racil Z
Leuk Lymphoma; 2013 Apr; 54(4):867-70. PubMed ID: 22950897
[No Abstract] [Full Text] [Related]
7. Detection of nucleophosmin and FMS-like tyrosine kinase-3 gene mutations in acute myeloid leukemia.
Pazhakh V; Zaker F; Alimoghaddam K; Atashrazm F
Ann Saudi Med; 2011; 31(1):45-50. PubMed ID: 21245599
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation.
Arana Rosainz MJ; Nguyen N; Wahed A; Lelenwa LC; Aakash N; Schaefer K; Rios A; Kanaan Z; Chen L
Int J Lab Hematol; 2021 Apr; 43(2):218-226. PubMed ID: 33099879
[TBL] [Abstract][Full Text] [Related]
9. Radar plots facilitate differential diagnosis of acute promyelocytic leukemia and NPM1+ acute myeloid leukemia by flow cytometry.
Gupta M; Jafari K; Rajab A; Wei C; Mazur J; Tierens A; Hyjek E; Musani R; Porwit A
Cytometry B Clin Cytom; 2021 Jul; 100(4):409-420. PubMed ID: 33301193
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of plasma specimens for detection of nucleophosmin 1 gene mutations in patients with normal karyotype acute myeloid leukemia.
Park SH; Min SK; Park BG; Jang S; Park CJ; Chi HS
Leuk Res; 2011 Sep; 35(9):e159-60. PubMed ID: 21600650
[No Abstract] [Full Text] [Related]
11. Integrative molecular subtypes of acute myeloid leukemia.
Mo Q; Yun S; Sallman DA; Vincelette ND; Peng G; Zhang L; Lancet JE; Padron E
Blood Cancer J; 2023 May; 13(1):71. PubMed ID: 37156780
[No Abstract] [Full Text] [Related]
12. Nucleophosmin (NPM1) mutations in acute myeloid leukemia: an ongoing (cytoplasmic) tale of dueling mutations and duality of molecular genetic testing methodologies.
Wertheim G; Bagg A
J Mol Diagn; 2008 May; 10(3):198-202. PubMed ID: 18403611
[TBL] [Abstract][Full Text] [Related]
13. Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study.
Matarraz S; Leoz P; Yeguas-Bermejo A; van der Velden V; Bras AE; Sánchez Gallego JI; Lecrevisse Q; Ayala-Bueno R; Teodosio C; Criado I; González-González M; Flores-Montero J; Avendaño A; Vidriales MB; Chillón MC; González T; García-Sanz R; Prieto Conde MI; Villamor N; Magnano L; Colado E; Fernández P; Sonneveld E; Philippé J; Reiterová M; Caballero Berrocal JC; Diaz-Gálvez FJ; Ramos F; Dávila Valls J; Manjón Sánchez R; Solano Tovar J; Calvo X; García Alonso L; Arenillas L; Alonso S; Fonseca A; Quirós Caso C; van Dongen JJM; Orfao A
Blood Cancer J; 2023 Sep; 13(1):132. PubMed ID: 37666856
[No Abstract] [Full Text] [Related]
14. Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use.
Lesieur A; Thomas X; Nibourel O; Boissel N; Fenwarth L; De Botton S; Fournier E; Celli-Lebras K; Raffoux E; Recher C; Lambert J; Berthon C; Pigneux A; Itzykson R; Turlure P; Pautas C; Vargaftig J; Preudhomme C; Dombret H; Duployez N
Haematologica; 2021 Jun; 106(6):1767-1769. PubMed ID: 33299234
[TBL] [Abstract][Full Text] [Related]
15. A novel quantitative assessment of minimal residual disease in patients with acute myeloid leukemia carrying NPM1 (nucleophosmin) exon 12 mutations.
Dvorakova D; Lengerova M; Pospisilova J; Palasek I; Mayer J
Leukemia; 2009 Apr; 23(4):793-6. PubMed ID: 18830256
[No Abstract] [Full Text] [Related]
16. Molecular study of Nucleophosmin 1(NPM1) gene in acute myeloid leukemia in Kurdish population.
Othman GO; Mohammad NS; Saeed CH
Afr Health Sci; 2021 Jun; 21(2):687-692. PubMed ID: 34795724
[TBL] [Abstract][Full Text] [Related]
17. Nucleophosmin mutation in de-novo acute myeloid leukemia.
Rastogi P; Naseem S; Varma N; Varma S
Asia Pac J Clin Oncol; 2016 Mar; 12(1):77-85. PubMed ID: 26669619
[TBL] [Abstract][Full Text] [Related]
18. Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implications.
Ma W; Kantarjian H; Zhang X; Jilani I; Sheikholeslami MR; Donahue AC; Ravandi F; Estey E; O'Brien S; Keating M; Giles FJ; Albitar M
Cancer Biomark; 2009; 5(1):51-8. PubMed ID: 19242062
[TBL] [Abstract][Full Text] [Related]
19. The International Consensus Classification of acute myeloid leukemia.
Weinberg OK; Porwit A; Orazi A; Hasserjian RP; Foucar K; Duncavage EJ; Arber DA
Virchows Arch; 2023 Jan; 482(1):27-37. PubMed ID: 36264379
[TBL] [Abstract][Full Text] [Related]
20. Residual disease by flow cytometry in patients with nucleophosmin-mutated acute myeloblastic leukemia.
Sorigue M; Espasa A; Zamora L; Junca J
Ann Hematol; 2020 May; 99(5):1135-1136. PubMed ID: 32170360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
